Egil Riveland, Torstein Valborgland, Anastasia Ushakova, Øyvind Skadberg, Trine Karlsen, Torstein Hole, Asbjørn Støylen, Håvard Dalen, Vibeke Videm, Elias Koppen, Axel Linke, Charles Delagardelle, Emeline M Van Craenenbroeck, Paul Beckers, Eva Prescott, Martin Halle, Torbjørn Omland, Øyvind Ellingsen, Alf Inge Larsen
AIMS: The aims of this sub-study of the SMARTEX trial were (1) to evaluate the effects of a 12-week exercise training programme on serum levels of high sensitivity cardiac troponin I (hs-cTnI) in patients with moderate chronic heart failure (CHF), in New York Heart Association class II-III with reduced ejection fraction (HFrEF) and (2) to explore the associations with left ventricular remodelling, functional capacity and filling pressures measured with N-terminal pro brain natriuretic peptide (NT-proBNP)...
January 24, 2024: ESC Heart Failure